Australia’s University of Sydney found that MDMA use (3,4-methylenedioxymethamphetamine or Ecstasy) in early adulthood appears to be associated with increased odds of anxiety disorders but not depressive disorder by the mid-30s.
Australia’s University of Sydney found that MDMA use (3,4-methylenedioxymethamphetamine or Ecstasy) in early adulthood appears to be associated with increased odds of anxiety disorders but not depressive disorder by the mid-30s.